| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +22.9% |
| Cost of Revenue | $140.2M | +21.9% |
| R&D Expense | $883.0M | +11.5% |
| SG&A Expense | $770.7M | +24.2% |
| Operating Income | -$785.1M | -10.8% |
| Interest Expense | $156.0M | +9.1% |
| Pre-tax Income | -$1.13B | -32.3% |
| Income Tax | $4.2M | +512.2% |
| Net Income | -$1.13B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $866.4M | +5.7% |
| Accounts Receivable | $238.0M | +19.8% |
| Inventory | $129.0M | +49.3% |
| Current Assets | $2.69B | -4.1% |
| Total Assets | $3.55B | -2.7% |
| Current Liabilities | $767.9M | +10.4% |
| Total Liabilities | $3.70B | +21.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$541.3M | +15.6% |
| Capital Expenditures | $72.1M | -5.6% |
| Investing Cash Flow | $169.4M | +162.0% |
| Financing Cash Flow | $425.8M | -65.9% |
| Free Cash Flow | -$613.3M | +14.6% |
| -32.6% |
| EPS (Basic) | -$9.30 | -29.2% |
| EPS (Diluted) | -$9.30 | -29.2% |
| Stockholders' Equity |
| -$158.2M |
| -126.9% |